Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3591_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
14
S. Vyas and A. Rao
Fig. 3.1 Ultrasound-guided biopsy: (a) in-plane and (b) out-of-plane approach
a
• USG allows simultaneous visualization of structures sur­rounding the target area like nerves, vessels, and hollow viscus to prevent inadvertent injury to the surrounding structures.
• Use of ultrasound reduces the number of unsuccessful attempts and thus obviates the need for multiple needle passes.
• USG reduces procedure time compared to blind proce­dures, causing a reduction in pain and stress experienced by patients.
Advances in ultrasonography technology—a comprehen-
sive review of details of the advances in ultrasonography is beyond the scope of the chapter; however, a few relevant advances are discussed briey here.
Needle tip visualization—various technological advances help in better needle tip placement, for example:
– Mechanical needle guides help keep the needle path in
the desired direction. Moreover, the use of 3D/4D ultrasonography and electronic beam steering helps in correct needle placement.
– Electromagnet-specialized sensors attached to the
probe and the needle help in the estimation of nee­dle position with the help of an external magnetic eld.
– Optical tracking is done by using recorded images of
the needle and probe, which helps in deciphering the relative position of both.
– Image fusion—Fusion of pre-procedural imaging with
real-time USG images creates a roadmap for needle advancement and thus helps in exact placement.
b
– Image-based needle tracking can also be achieved by
means of advanced image processing algorithms [4]..
– ARFI is helpful in the detection of out-of-plane
approach of a needle based on the mechanical response of various tissues to USG beam.
– Robotic assistance for needle placement is also used in
the experimental stage.
Spatial compound imaging—this utilizes multiple angu­lated ultrasound beams combined to form a compound image, which is helpful in the reduction of artifacts like posterior acoustic shadowing, refractile shadowing, and anisotropy. It helps in improved delineation of tissue planes, vessels, nerves, and needle tip, in addition to pro­viding a larger trapezoidal eld of image.
Doppler mode including power Doppler—doppler mode helps in the visualization of vascular structures and helps in the assessment of ow-related parameters. Power Doppler is even more sensitive in demonstrating low amplitude vascularity, however, with loss of directional ow information.
Ultrasound elastography—this is a relatively recent advance that measures tissue stiffness. Elastography has proven helpful in differentiating benign and malignant masses, especially in the breast, liver, and thyroid, diag­nosing degeneration of tendinous/ligamentous structures, and also has found application in treatment response assessment.
Computer-aided detection (CAD)—CAD utilizes various computational algorithms to enhance image interpreta­tions, especially in training radiologists. CAD based on TIRADS and BIRADS has shown promise in lesion iden­tication and diagnosis [5, 6].
3 Image Guidance inInterventional Radiology
15
3.2.2 Indications ofUSG-Guided Interventions
1. Biopsy and ne needle aspiration [7].
2. Placement of drains.
3. Nerve blocks.
4. Ultrasound-guided central and peripheral venous access:
ultrasound is useful not only in deciding on the site of venous access but also the suitability of vein, progression of catheter or guidewire, needle tip visualization, and assessment of complications like pneumothorax, hema­toma, vascular thrombosis, and catheter malposition.
5. Transvaginal procedures—aspiration of adnexal cyst,
collection, egg retrieval [8].
6. Intra articular and synovial injections.
7. Breast marker/wire localizer placement.
8. USG-guided ablative procedures [9].
3.2.3 Limitations
1. Limited visualization of deeper structures as the resolu-
tion of ultrasonography is inversely proportional to the depth of area of interest.
2. Image degradation and beam attenuation in obese
subjects.
3. The presence of air in the tissues causes artifacts like
reverberation artifacts and dirty shadowing.
4. Limited visualization due to small acoustic window in
intercostal spaces and other structures.

3.3 Fluoroscopy

throgram (RGU), micturating cystourethrogram (MCU), tra­cheoesophageal stula (TEF), intestinal malrotation, and arthrography.
3.3.2 Interventional Fluoroscopy
1. Intussusception reduction
2. Hysterosalpingography
3.3.2.1 Digital Subtraction Angiography
Digital subtraction angiography (DSA) is a type of uoros­copy procedure that involves subtraction of bone and other radiopaque structures like soft tissue from a uoroscopy image so as to improve visualization of contrast-opacied vascular structures. It is an extremely valuable tool for inter­ventional radiology as many diagnostic and therapeutic pro­cedures are performed using DSA. The process involves obtaining a pre-contrast injection image (mask image), fol­lowing which intraluminal contrast is injected and succes­sive images obtained. The post-contrast image is subtracted from the mask image to reveal an image that shows contrast­opacied structures to greater advantage [1, 10].
3.3.3 Advantages ofDSA Include
1. Less invasive than open/surgical procedures.
2. Able to access difcult to reach, small vascular structures precisely with microcatheters.
3. Real-time manipulation can be performed.
4. Cost effective as it requires shorter hospital stays com­pared to open surgical procedures.
Fluoroscopy has been a valuable tool in interventional radi­ology; however, due to radiation exposure not only to the patient but also to the operator as well, its widespread use has been discontinued. The advent of multiple advancements in cross-sectional imaging like CT, MRI, and USG has led to limited current use of uoroscopy for diagnostic and inter­ventional radiology. It, however, continues to show advan­tages over invasive surgical procedures [10]. Insufcient training for residents and fewer staff with adequate expertise also contribute to its declining use.
3.3.1 Indications
Diagnostic uoroscopy procedures form the current main­stay of procedures performed nowadays, notable among them being esophageal abnormalities (like achalasia, esoph­ageal pseudo diverticulosis, and benign and malignant stric­tures), postoperative setting (demonstration of leak), myelography, hysterosalpingography (HSG), retrograde ure-
3.3.4 Indications ofDSA
1. Drainage procedures
2. Diagnosis and treatment of obstructive and non­obstructive vascular diseases
3. Functional assessment of vascular structures
4. Angioplasty and venoplasty
5. Vascular stenting
6. Placement of vascular lters
7. Evaluation of graft anatomy and patency
8. Treatment of vascular leaks and injuries
9. Retrieval of catheters and guidewires
3.3.5 Limitations ofDSA
1. Ionizing radiation
2. Limited spatial resolution
3. Small eld of work
16
S. Vyas and A. Rao
Various complications that can be seen in DSA proce­dures are vessel thrombosis, bleeding, pseudoaneurysm for­mation, arteriovenous stulation, vascular dissection, embolism and breakage of hardware, and adverse contrast reaction.

3.4 Computed Tomography

CT is widely used for a variety of interventional procedures like biopsy, drainage procedures, and ablations at many cen­ters. Two approaches may be used in CT guidance: the step­and-shoot approach and the CT uoroscopy approach. While the former allows control of radiation exposure and 3D capa­bility, it does not allow real-time visualization of the needle tip and lesion, which may be inuenced by patient compli­ance and motion. The CT uoroscopy, on the other hand, allows real-time visualization at the expense of increased radiation exposure for both the patient and the operator [11,
12]. Advances like robotic guidance and augmented reality
guidance are under investigation to further ne tune the pro­cedures [2, 1315]. Respiratory motion, cardiac pulsations, and patient movement make CT-guided intervention proce­dures challenging as in other guiding modalities.
3.4.1 Advantages ofCT-Guided Interventions
1. CT can visualise areas adjacent to bony structures and air
containing areas which are not accessible to USG beam.
2. CT allows access to deep-seated posterior areas in abdo-
men and pelvis.
3. High spatial and contrast resolution of CT allows accu-
rate demarcation of target area.
4. Precise localization of lesion and near real-time visual-
ization as repeated scans are undertaken with progressive needle advancement.
5. 3D capability of CT allows accurate spatial correlation
for needle advancement.
6. Use of intravenous contrast agents allows the use of
enhancement characteristics of target lesion as well as delineate vascular and non-enhancing necrotic foci.
3.4.3 Limitations
1. Radiation exposure and need for repeated scanning as the needle advances to reach the target.
2. Need for iodinated contrast injection if the lesion is better visualized in a particular phase of enhancement and if there is proximity to vascular structures, which may be associated with adverse effects.
3. Repeated scanning increases radiation exposure to both the subject and the operator.

3.5 Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) has numerous advan­tages over previously mentioned imaging modalities like uoroscopy and CT, in addition to having the highest soft tissue resolution. However, historically, MRI-based inter­ventions have been limited, owing to the limited availability of MRI conditional hardware as well as non-availability of MRI scanners. The technical advancements from the earlier biplanar low-eld interventional MR systems to the current higher eld strength wide short bore magnets has revolution­ized the interventional capabilities of MRI [16]. Moreover, tailoring of various MRI sequences have improved the visu­alization of the needle track and the ablation zones. It should be remembered that there is a tradeoff between the signal-to­noise ratio and acquisition speed, as needle placement requires higher temporal resolution sequences like GRE or SSFSE, which lead to increased susceptibility artifacts and lower spatial resolution [1719].
There are several factors that must be taken into account
pertaining to safety inside the interventional MRI suite:
1. Projectile effects of ferrous objects in strong magnetic elds can pose a risk to the patient and healthcare person­nel. Standard and strict safety protocols are needed to be implemented in the interventional MRI suite.
2. Heating of metallic devices can be caused by the radiofre­quency eld during MRI procedure.
3. Loud noise produced by rapid switching of magnetic elds can cause hearing loss due to prolonged exposure.
3.4.2 Indications
1. Biopsy/FNA procedures of lung, liver, adrenal, and bone
2. Tubes and drainage procedures like abdominopelvic drainages
3. Ablation—radiofrequency ablation, microwave ablation of tumors, osteoid osteoma
3.5.1 Advantages ofMRI-Guided Interventions
1. Soft-tissue contrast resolution is high with MRI, thus
exact and accurate localization and targeting of abnor­mality can be performed.
2. High sensitivity to liver, prostate, bone, and breast focal
lesions.
3. Multiplanar capability.
3 Image Guidance inInterventional Radiology
17
4. No risk of ionizing radiation.
5. Ability to fuse images with other modalities like ultra­sound, CT, PET CT, etc.
3.5.2 Indications ofMRI-Guided
Interventions
1. Biopsy of lesions visualized only on MRI scan.
2. Cryoablation of malignant and non-malignant lesions with superior visualization and monitoring of ice ball during cryoablation and thermal ablation during RFA, MWA, laser ablation, and MR-guided FUS.
3. Sclerotherapy of poorly visualized lesions on ultrasound as MRI shows high T2 signal of these lesions.
3.5.3 Limitations
1. Longer scanning time is required with MRI.
2. Limited availability of MRI conditional and MRI com­patible devices.
3. High cost of MRI.
3.6 Dose Reduction Techniques
andRecent Advances
The healthcare team in an IR suite is responsible for the radi­ation safety in the workplace by keeping radiation exposure to staff and the patient to “as low as reasonably achievable” (ALARA). The main objective is minimizing the unneces­sary and unwarranted radiation exposure while maintaining adequate image quality. It is vitally important to understand the key principles of occupational and public radiation pro­tection (justication, optimization of protection, and dose limitation).
3.6.1 Dose Reduction inFluoroscopy
While the improvement in patient care with uoroscopy is undoubted, the equipment is capable of producing large amounts of radiation output, which can create serious conse­quences for the patient and operator [20, 21]. The main source of exposure to the patient is the x-ray beam, whereas for the operator it is the scatter radiation. Various techniques that have been employed to ensure the same are enumerated as follows [2023]:
Default setting: A default setting determines the rate of
radiation production prior to the procedure. Activation of an appropriate default setting helps to maintain the image
quality while limiting the radiation dose. The operator can manually change the settings based on the need.
Pulsed uoroscopy: A series of short bursts of x-rays is used instead of a continuous x-ray emission. An increased pulse rate increases the temporal resolution concurrently leading to a higher radiation exposure. Hence, the pulse rate is determined by the operator based on need for tem­poral resolution. A 50% reduction in pulse rate results in 30% reduction in dose.
Higher kVp: The amount of x-rays produced is dependent on kVp and mA.It is directly related to kVp; however, the relationship is not linear. Increasing the voltage by 15% doubles the amount of x-rays; the general rule is to use the highest kVp to achieve minimally acceptable image quality.
Tube current: The number of x-rays produced by the x-ray tube is determined by the tube current. Increase in tube current reduces noise, concurrently increasing the radia­tion dose. Since patient dose increases more rapidly than noise decreases, it is not an ideal way to improve image quality.
Beam ltration: Higher energy x-rays reach the image receptor contributing to image quality, whereas the low­energy x-rays are primarily absorbed by the patient leading to unwarranted radiation exposure. Beam ltra­tion removes low-energy x-rays from the uoroscopic beam (bremsstrahlung curve is shifted to right), reduc­ing the radiation dose while maintaining the image quality. Copper is a common lter used in uoroscopic units, thickness of 0.1–0.9 mm in interventional uoroscopy.
Automated brightness control/Automated exposure rate control (ABC/AEC): It is a feedback control loop that allows automatic variation in tube current, tube voltage, pulse width, and/or added ltration in response to tissue thickness and attenuation.
Last-image hold (LIH): The last image of the uoroscopic sequence is retained on the monitor after the pedal is released. This allows its careful inspection without further irradiation.
Fluoro save (FS) or uoro grab: The operator can select and store the LIH or grab a uoroscopic image during live uoroscopy. The FS spares the additional dose of digital radiographic image which is approximately 10 times higher.
Last uoro loop replay: This allows the operator to save the last uoroscopic sequence by pushing a button when the uoroscopic pedal is released.
Source to skin distance: It is the distance between focal spot in x-ray tube and entrance plane of patient body. Small increase in SSD causes a signicant reduction in radiation dose, e.g., doubling SSD—decreases radiation dose to 25%.
18
S. Vyas and A. Rao
Source to image receptor distance: It represents distance between focal spot and image receptor. A small decrease in SID causes a signicant decrease in radiation output.
Air gap: It corresponds to the distance between patient and image receptor and directly proportional to the amount of scatter radiation. Reducing the air gap, decreasing the scatter radiation, and a resultant decreased exposure to the operator.
Collimation: It controls the cross-sectional area of the pri­mary x-ray beam to which the patient is exposed. Avoid unnecessary radiation exposure (especially radiosensitive organs, such as breast, thyroid, eyes, and gonads).
Image receptor: A larger image receptor absorbs more x-rays that is transmitted from the patient, henceforth reducing the scatter radiation and a consequent reduction in operator exposure.
3.6.2 Special Considerations ofRadiation
Protection inPediatric Population
Children are more radiosensitive than adults for approxi­mately 30% of cancers (thyroid and leukemia, etc.) [2225]. They have a higher tendency to develop cancer also because of higher life expectancy after a radiological procedure. The general techniques for radiation safety are the same as described above, except a few as mentioned below.
3.6.3 Remove Anti-scatter Grid
3.6.5 Checklist
A step-by-step checklist should be part of institutional proto­col to ensure compliance of ALARA principle.
To Check Pre-procedure
1. Appropriate history of prior radiation exposure (diagnos­tic and therapeutic).
2. History of adverse reaction to previous radiation exposure.
3. Adequately informed consent for the procedure, espe­cially if it entails a large exposure. For cases in which high radiation exposure is expected, a discussion of adverse effects of radiation is a must. A detailed discus­sion is also warranted before imaging pregnant patients.
4. Radiologist and technical staff should explore alternate imaging like ultrasound and MRI for the clinical indica­tion. This is even more relevant when repeated imaging follow up is required.
5. Use of appropriate radiation protection gear like apron, glasses, thyroid shield by operators (lead aprons should have 0.5mm Pb equivalent front and 0.25mm Pb equiva­lent on sides and back).
6. Mandatory use of personnel dosimeters (in radiation room, staff should war the radiation dosimeters on collar outside the lead apron and front of torso underneath apron).
7. Patient positioning should be such that hanging lead shield/skirt/rolling shield can be used optimally.
8. Use of pediatric presets and setting of protocol based on patient’s weight and size.
Radiographic equipment for pediatric population should have provision to remove the grid easily. Patients with weight of less than 18–20kg do not generate enough scatter radia­tion to cause signicant degradation of image quality. If grid is not used in such patients, the small amount of scatter radi­ation generated will contribute to the required dose for opti­mum image production. This is especially true for radiography involving high inherent contrast regions like chest and barium/iodinated contrast studies [26, 27]. A tight collimation is usually enough to keep the radiation dose low.
3.6.4 Pulsed Fluoroscopy
Appropriate pulse rate in a pediatric age group is as follows [24, 25]:
Pediatric cardiac studies—30 pulse per second Non-cardiac interventional studies—15 pulses per second General uoroscopic study (GI or GU)—1–4 pulses per
second
To Check During the Procedure
1. X-ray beam collimation.
2. High source to object distance.
3. Image intensier to be as close to subject as possible.
This is not relevant while using the air-gap technique for geometric magnication.
4. Low-pulse rate in uoroscopy.
5. Last-image hold whenever feasible.
6. Source-to-object distance is as large as possible.
7. Image intensier is as close as possible to the patient to
reduce radiation scatter, except when deliberately using air-gap technique for geometric magnication.
8. During lateral view, keep arm out of the exposure.
9. Minimum staff in the exposure room.
10. In case substantial radiation dose levels (SRDL) are
exceeded, postponing of the study be considered depend­ing on clinical scenario.
To Check Post-procedure
1. Check the record of patient dose metrics.
2. If dose exceeds thresholds, appropriate counseling of the patient/attendant/guardian should be done.
3 Image Guidance inInterventional Radiology
19
3.7 Dose Reduction inCT
Radiation dose during a CT guided intervention is affected by patient habitus, gantry rotation, pitch, slice thickness, number of slices, area of imaging, tube voltage, and tube cur­rent. Various measures to reduce dosage can be done during the pre-procedure scan, during the procedure, and at post­procedure scan times [20, 21, 23, 27].
• Pre-procedure scan—During the pre-procedure scan, the length of the scan should include only the area of interest. Moreover, the tube current can be reduced as diagnostic quality imaging is not required, rather the scanning is done to localize and mark the point of entry.
• During procedure—Once the area of interest is localized, intermittent CT uoroscopy can be used with reduced kVp and mAs setting. It should, however, be remembered that a reduction in mAs may not be possible in obese sub­jects, especially in thickset body parts like lower abdo­men and pelvis, where reduction in mAs might lead to poor visualization of needle/guidewire due to increased noise. In areas with inherent high contrast like thorax and in thinset body parts, mAs reduction is extremely useful.
• Post-procedure scan—Post-procedure scan is advisable to conrm placement of various tubes/catheters and to screen for complications like bleeding and pneumotho­rax. Here also, the use of low mAs scanning is advisable with the lowest scan length to reduce radiation exposure.
3.8 Special Considerations inPregnancy
Interventional radiologists play a key role in managing vari­ous complications of pregnancy during gestation and post­partum period. Various such complications include ectopic pregnancy, symptomatic ovarian cysts, obstructive uropathy in the antepartum and hemorrhage, post-cesarean section abscess, and vesicouterine stula in the postpartum period. Previously, surgery was considered the mainstay of manage­ment. However, surgery imposes a short-term risk of mater­nal/fetal morbidity and mortality or a long-term loss of fertility. IR provides therapeutic options that obviates sur­gery, henceforth reduces maternal/fetal morbidity and pre­serves fertility [28, 29]. The maternal and fetal radiation exposure during these procedures is also a matter of concern due to possible long-term negative effects, making it impera­tive to restrict the radiation exposure to minimum necessary.
Indications include
• USG-directed chemical injection in ectopic sac.
• Uterine artery embolization if adhesive placental disor­ders, atonic PPH.
• Glue obliteration of uterine AVM nidus as part of fertility preserving procedure.
• Percutaneous nephrostomy in pregnancy-related obstruc­tive uropathy.
• Percutaneous suprapubic cystostomy for bladder drainage in traumatic vesicouterine stula.

3.9 Conclusion

Various radiological modalities are used to guide interven­tional procedures, each with their unique advantages and limitations. The modality that best depicts and is best suit­able for a specic clinical scenario is often decided based on multidisciplinary discussion, local expertise, and availabil­ity of equipment, so as to provide optimum care to the patients.

References

1. Rehani MM, Miller DL, Baliyan V. High-dose uoroscopically guided procedures in patients: radiation management recom­mendations for interventionalists. Cardiovasc Intervent Radiol. 2021;44(6):849–56.
2. Anzidei M, Argirò R, Porri A, Boni F, et al. Preliminary clini­cal experience with a dedicated interventional robotic system for CT-guided biopsies of lung lesions: a comparison with the conven­tional manual technique. Eur Radiol. 2015;25(5):1310–6.
3. Douglas BR, Charboneau JW, Reading CC. Ultrasound-guided intervention: expanding horizons. Radiol Clin North Am. 2001;39:415–28.
4. Lee MW.Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography. 2014;33(4):227–39.
https://doi.org/10.14366/usg.14021. Epub 2014 Jun 10. PMID:
25036756; PMCID: PMC4176112.
5. Zhang Y, Wu Q, Chen Y, Wang Y.A clinical assessment of an ultra­sound computer-aided diagnosis system in differentiating thyroid nodules with radiologists of different diagnostic experience. Front Oncol. 2020;10:557169.
6. Moon WK, Lee Y-W, Ke H-H, Lee SH, Huang C-S, Chang R-F.Computer-aided diagnosis of breast ultrasound images using ensemble learning from convolutional neural networks. Comput Methods Prog Biomed. 2020;190:105361.
7. Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES.Renal masses in the adult patient: the role of percutaneous biopsy. Radiology. 2006;240:6–22.
8. O’Neill MJ, Rafferty EA, Lee SI, Arellano RS, Gervais DA, Hahn PF, etal. Transvaginal interventional procedures: aspiration, biopsy, and catheter drainage. Radiographics. 2001;21:657–72.
9. Veltri A, De Fazio G, Maltana V, Isolato G, Fontana D, Tizzani A, etal. Percutaneous US-guided RF thermal ablation for malig­nant renal tumors: preliminary results in 13 patients. Eur Radiol. 2004;14:2303–10.
10. Pooley RA, McKinney JM, Miller DA.The AAPM/RSNA phys­ics tutorial for residents: digital uoroscopy. Radiographics. 2001;21(2):521–34.
11. Schmidbauer J, Remzi M, Memarsadeghi M, Haitel A, Klingler HC, Katzenbeisser D, et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol. 2008;53:1003–11.
20
S. Vyas and A. Rao
12. Harinsinghani MG, Gervais DA, Hahn PF, et al. CT-guided transgluteal drainage of deep pelvic abscesses: indications, tech­nique, procedure-related complications, and clinical outcome. Radiographics. 2002;22:1353–67.
13. Robert B, Yzet T, Regimbeau JM.Radiologic drainage of postop­erative collections and abscesses. J Visc Surg. 2013;1505:511–8.
14. Ning Z, Qian L, et al. CT-guided special approaches for intra abdominal and pelvic abscesses. Medicine (Baltimora). 2018;97(42):e12905.
15. Aganà D, Carraello G, Mangini M, etal. Image-guided percutane­ous treatment of abdominal-pelvic abscesses: a 5-year experience. Radiol Med. 2008;113:999.
16. Merkle EM, Lewin JS, Liebenthal R, Lorenz CH. The interven­tional MR imaging suite: magnet designs and equipment require­ments. Magn Reson Imaging Clin N Am. 2005;13(3):401–13.
17. Sedaghat F, Tuncali K. Enabling technology for MRI-guided intervention. Top Magn Reson Imaging. 2018;27(1):5–8. https://
doi.org/10.1097/RMR.0000000000000148. PMID: 29406409;
PMCID: PMC5805398.
18. Thompson SM, Gorny KR, KnavelKoepsel EM, Welch BT, Mynderse L, Lu A, Favazza CP, Felmlee JP, Woodrum DA.Body interventional MRI for diagnostic and interventional radi­ologists: current practice and future prospects. Radiographics. 2021;41(6):1785–801.
19. Kaye EA, Granlund KL, Morris EA, Maybody M, Solomon SB. Closed-bore interventional MRI: percutaneous biopsies and ablations. AJR Am J Roentgenol. 2015;205(4):W400–10.
20. Walsh SR, Cousins C, Tang TY, Gaunt ME, J.R. Boyle ioniz­ing radiation in endovascular interventions. J Endovasc Ther. 2008;15:680–7.
21. Wagner JB.Radiation protection and safety in interventional radi­ology. Radiol Technol. 2020;91(5):431–42.
22. Ploussi A, Brountzos E, Rammos S, Apostolopoulou S, Efstathopoulos EP.Radiation exposure in pediatric interventional procedures. Cardiovasc Intervent Radiol. 2021;44(6):857–65.
https://doi.org/10.1007/s00270- 020- 02752- 7. Epub 2021 May 19.
23. Schueler BA, Balter S, Miller DL. Radiation protection tools in interventional radiology. J Am Coll Radiol. 2012;9(11):844–5.
https://doi.org/10.1016/j.jacr.2012.08.003.
24. ICRP, Khong PL, Ringertz H, Donoghue V, Frush D, Rehani M, Appelgate K, Sanchez R.ICRP publication 121: radiological pro­tection in paediatric diagnostic and interventional radiology. Ann ICRP. 2013;42(2):1–63. https://doi.org/10.1016/j.icrp.2012.10.001. PMID: 23218172.
25. Sidhu M.Radiation safety in pediatric interventional radiology: step lightly. Pediatr Radiol. 2010;40(4):511–3. https://doi.org/10.1007/
s00247- 009- 1514- 0. PMID: 20225114.
26. Hernanz-Schulman M, Goske MJ, Bercha IH, Strauss KJ. Pause and pulse: ten steps that help manage radiation dose during pediat­ric uoroscopy. AJR Am J Roentgenol. 2011;197:475–81.
27. Fritz S, Kyle JA.Guidelines for anti-scatter grid use in pediatric digital radiography. Pediatr Radiol. 2014;44(3):313–21.
28. Chintapalli KN, Montgomery RS, Hatab M, etal. Radiation dose management: part 1, minimizing radiation dose in CT-guided pro­cedures. AJR Am J Roentgenol. 2012;198:W347–51.
29. Morgan TA, Jha P, Feldstein VA, Shum DJ, Pōder L.US-guided interventions to diagnose and treat gynecologic and rst-trimester disease. Radiographics. 2021;41(6):E183–4.
Contrast andDrugs inInterventional Radiology
SnehaGoswami, SmitaManchanda, AshuSeithBhalla, andPriyankaNaranje
4
Key Messages
1. Iodinated contrast media (ICM) are crucial for radiologi­cal procedures, with risk mitigation strategies including proper hydration and low or iso-osmolar agents.
2. Carbon dioxide (CO2) serves as a negative contrast agent, offering an alternative in patients with iodinated contrast contraindications, requiring proper administra­tion technique.
3. Thrombolytics like alteplase and tenecteplase are effec­tive for arterial ischemia and venous thrombosis but have contraindications such as active bleeding.
4. Anticoagulants like unfractionated heparin and novel oral anticoagulants prevent thrombus formation with specic indications and monitoring needs.
5. Antiplatelet drugs such as aspirin and clopidogrel inhibit platelet aggregation, requiring careful management before high-risk procedures.
6. Reversible P2Y12 inhibitors like ticagrelor and cangre­lor prevent platelet aggregation with specic dosing regimens and routes of administration.
7. Glycoprotein IIb/IIIa inhibitors block platelet aggrega­tion and are administered intravenously, with varying durations of action.
8. Vasodilators like nitroglycerine and verapamil relieve arterial spasm, each with specic indications and dosing considerations.
9. Vasopressin induces vascular smooth muscle contrac­tion and is primarily used for acute gastroenterological bleeding, with tailored dosing protocols.
10. Thrombin accelerates clot formation and is used for treating pseudoaneurysms, requiring careful patient selection and monitoring.

4.1 Introduction

Over the past few years, there has been a tremendous increase in indications for various vascular and non-vascular proce­dures performed in the interventional radiology suite with advances in technology in imaging equipment, tools, and pharmacologic agents. With the growing indications and sev­eral interventional radiological procedures performed, it has become necessary for the radiologist to know about the uses, side effects, and various interactions of these pharmaceutical agents that can potentially lead to adverse consequences for the patient. Therefore, radiologists and their staff need to be aware of these risks to be able to prevent and manage them as well. This chapter includes various commonly used con­trast agents and drugs that are used during interventional radiological procedures (Table4.1, Fig.4.1).
Table 4.1 Classes of pharmaceutical agents used commonly in inter­ventional radiology
I.Contrast agents
• Iodinated contrast agents: Iopamidol, iomeprol, iopromide, and iohexol
• Carbon dioxide (CO
II.Anticoagulation and antiplatelet medications
• Thrombolytics: Prourokinase, Rt-PA (recombinant tissue
plasminogen activator), streptokinase, urokinase
• Anticoagulants: Unfractionated heparin (UFH), low molecular-
weight heparins (LMWH)
• Antiplatelets: Aspirin, clopidogrel, dipyridamole, glycoprotein
IIb/IIIa inhibitors III. Vasodilators: Nitroglycerin, verapamil IV. Vasoconstrictors: Vasopressin, desmopressin V. Prothrombotics: Thrombin
) as a negative contrast agent
2
S. Goswami · S. Manchanda (*) · A. S. Bhalla · P. Naranje Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, Delhi, India
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024 S. H. Chandrashekhara (ed.), Textbook of Interventional Radiology, https://doi.org/10.1007/978-981-97-9601-4_4
21
22
fg
bc
S. Goswami et al.
Fig. 4.1 (a) Iopromide (Ultravist, conc. 370mg L/ mL); (b) Iohexol (Omnipaque, 350mg L/mL); (c) Iomeprol (Iomeron, 400mg L/mL); (d) Thrombolytic: Streptokinase; (e) Anticoagulant: Unfractionated heparin; (f) Vasoconstrictor: Vasopressin; and (g) Vasodilator: Nitroglycerin
a
de

4.2 Pharmaceutical Agents

4.2.1 Contrast Agents
For most radiological procedures, diagnostic or interventional, contrast media have a crucial role in providing accurate diag­noses by improving contrast. An ideal contrast agent is water soluble, chemically stable, biologically inert, and low in vis­cosity with osmolality same or lower than human serum, safe, and cost-effective [1]. Contrast agents can be classied as positive or negative; positive contrast agents are more radi­opaque than the surrounding tissue, e.g., iodinated contrasts and barium sulfate, while negative contrast agents are gases of low density and appear radiolucent, e.g., carbon dioxide [2].
For safe administration and favorable outcomes, the areas to be focused upon are screening, patient selection, premedi­cation, and treatment of adverse events.
4.2.2 Iodinated Contrast Media (ICM)
Iodinated contrast agents are the most commonly used intra­vascular agents in interventional radiology. These are gener­ally considered safe when appropriately administered, however, life-threatening reactions are known to occur, and risk in patients with impaired renal function is well estab­lished. Therefore, it is important to be aware of the various
contrast reactions as well as the current guidelines for the prevention and management of these complications. American College of Radiology manual lays down the guidelines for contrast media administration and manage­ment of related complications [3].
4.2.2.1 Basic Chemistry ofICM
Benzene is the parent molecule of iodinated contrast media, and the carbon atoms are numbered in a clockwise manner from 1 to 6. By introducing iodine atoms at second, fourth, and sixth locations, we get a tri-iodinated benzene ring that is common among all ICM [4].
Iodine has a higher atomic number and weight (atomic weight 127) and K shell electron binding energy (34keV) which increases the likelihood of a photoelectric effect as it is near the mean energy used in diagnostic X-rays, thereby improving the image quality [5].
4.2.2.2 Types ofICM
Iodine-based contrast agents are divided according to osmo­lality (high, low, or iso-osmolar) compared with the human serum, ionicity (ionic or non-ionic), and the number of ben­zene rings (monomer or dimer depending upon the number of benzene rings in each molecule) [6]. The osmolality of high-osmolar contrast media (HOCM) is approximately 1400 mOsm/kg H2O osmolality which is about 5–8 times the osmolarity of the plasma [7].
4 Contrast andDrugs inInterventional Radiology
23
Low-osmolar contrast media (LOCM) were developed in the 1970s and have largely supplanted HOCM in clinical use. All are able to carry three iodine particles per one osmotic particle (3:1 ratio) and most are non-ionic as they have covalent bonding. They do not dissociate in the plasma due to which lesser osmotically active particles are available, and therefore, they are low in osmolality (600–900mOsm) [7]. Ioxaglate (Hexabrix®, Covidien plc, Dublin, Ireland) being an ionic dimer is an exception. It is an ionic LOCM and carries six iodine particles per two osmotic particles and dissociates in plasma, also resulting in a ratio of three iodine particles to a single osmotic particle [8].
Iso-osmolar contrast media (IOCM) are the newest con­trast agents. They are nonionic dimers allowing six iodine particles to be attached to one osmotic particle (6:1 ratio). This results in a contrast medium that is iso-osmolar (300 mOsm) to plasma [8]. In patients with normal renal function, LOCM is preferred over HOCM as these are better tolerated and have fewer side effects. In high-risk patients, IOCM is preferred over LOCM for IA administration as despite a lack of any compelling evidence in the literature of its safety over LOCM, however, IOCM has better tolerance.
LOCM and IOCM are used in angiography as they are associated with the least amount of vasospasm and also the least peripheral discomfort during peripheral angiograms [9]. Several studies demonstrated that iodixanol is associated with less pain and heat discomfort [10]. Better tolerance poten­tially leads to fewer motion artifact and better image quality during digital subtraction angiography (DSA) acquisition. This eventually results in reduced contrast and radiation dose.
4.2.2.3 Post-contrast Acute Kidney Injury
andContrast-Associated Acute Kidney Injury (CA-AKI)
Contrast-associated acute kidney injury (CA-AKI) describes a sudden renal dysfunction occurring within 48h of admin­istration of intravascular iodinated contrast media. It is to be noted that this does not necessarily implicate contrast medium as the cause of renal dysfunction [1120].
Previously termed contrast-induced nephropathy, contrast- induced acute kidney injury (CI-AKI) is dened as a sudden deterioration in renal function caused by the intra­vascular administration of iodinated contrast medium; hence, CI-AKI is a subgroup of CA-AKI.
While there are only a limited number of studies that have a suitable control group, reported incidence in CA-AKI includes a combination of both CA-AKI and CI-AKI.However, the reader should note that these are not synonymous terms [1120].
Pathogenesis
The pathophysiology of CI-AKI remains elusive. Various con­tributing factors such as direct tubular toxicity and altered renal hemodynamics (vasoconstriction) have been proposed [2131].
Risk Factors
The most important risk factor is pre-existing severe renal function impairment. Other risk factors include diabetes mellitus, hypertension, cardiovascular disease, hyperurice­mia, diuretics, old age, and administration of multiple doses of contrast medium within 24h [3, 13, 3235].
Various equations are available to provide a theoretical threshold value for the maximal contrast dose that can be administered; however, these equations have limitations that should be considered. It is to be noted that multiple myeloma is not considered a risk factor [3638].
The risk of CI-AKI is much higher with cardiac angiogra­phy compared to intravenous administration of contrast medium due to these reasons: intra-arterial and supra-renal injection; more abrupt and concentrated contrast medium dose to the kidneys; and catheter used for the injection can disrupt atheroemboli [12, 15, 39].
Choice ofContrast
In patients having renal functional impairment, LOCM is considered less nephrotoxic than HOCM and should be pre­ferred [40]. There is no evidence to suggest a higher risk of nephrotoxicity associated with HOCM in patients having normal renal function.
There is also no evidence in the current literature to sug­gest that IOCM is better than LOCM in terms of risk of developing nephrotoxicity [4144].
Diagnosis
Diagnosis of CA-AKI is based upon the Kidney Disease Improving Global Outcomes (KDIGO) criteria for AKI, which is common for dening intrinsic acute kidney injury regardless of etiology [4547]. Therefore, it can be used to dene the parameters of CA-AKI as well as CI-AKI.
According to KDIGO criteria, AKI is diagnosed if one of the following occurs within 48h after a nephrotoxic event (e.g., intravascular iodinated contrast medium exposure) [46]:
(i) An absolute rise in serum creatinine ≥0.3 mg/dL
(>26.4μmol/L)
(ii) 50% (1.5-fold above baseline) increase in the serum
creatinine or
(iii) Urine output reduced to 0.5mL/kg/h for at least 6h
It should be kept in mind that elevations in serum creati­nine are neither sensitive nor specic for individual types of AKI.
Risk Threshold
There is no denite and widely accepted threshold of serum creatinine or eGFR beyond which intravascular ICM should never be administered due to the risk of CI-AKI [3]. However, most evidence-based threshold value is 30mL/min/1.73m
2
if a threshold value needs to be considered [13].